Pfizer to expand tests of COVID-19 vaccine in children below 12
Al Jazeera
New study to enroll thousands of children below 12 years at dozens of sites across the US, Finland, Poland and Spain.
Pfizer has said it will begin testing its COVID-19 vaccine in a larger group of children below 12 years of age after selecting a lower dose of the shot in an earlier stage of the trial. The study will enrol up to 4,500 children at more than 90 clinical sites in the United States, Finland, Poland and Spain, the pharma company said. The vaccine made by Pfizer and its German partner BioNTech is already authorised for emergency use in anyone 12 and older in the US, Canada and the European Union. They receive the same dose as adults: 30 micrograms.
The US president has proven that hitting hard and fast rather than engaging in endless negotiations guarantees victory.
Lebanon fears that Israel’s attack on Qasmiyeh Bridge could be a “prelude to a ground invasion”.
Donald Trump’s Strait of Hormuz deadline for Iran raises concerns about attacks on energy in the Middle East.
Members of the International Energy Agency have agreed to release 400 million barrels of oil from strategic reserves.
Democrats and other observers slam deployment of US immigration agents to airports as dangerous and source of tension.
Locals in northern India have a growing concern over costs of essential resources due to the Iran war.
Esmaeil Baghaei denies the long-range missile attack, which could change the calculus of the war for US allies.
